A phase II study of ALLN-177 in adolescents and adults with primary hyperoxaluria or severe forms of secondary hyperoxaluria
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2018
At a glance
- Drugs ALLN 177 (Primary)
- Indications Primary hyperoxaluria
- Focus Therapeutic Use
- 27 Mar 2018 Status changed from not yet recruiting to recruiting, according to an Allena Pharmaceuticals media release.
- 04 Jan 2018 Status changed from planning to not yet recruiting.
- 20 Dec 2017 New trial record